Invivo Therapeutics Holdings Stock Number Of Shares Shorted
InVivo Therapeutics Holdings fundamentals help investors to digest information that contributes to InVivo Therapeutics' financial success or failures. It also enables traders to predict the movement of InVivo Stock. The fundamental analysis module provides a way to measure InVivo Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InVivo Therapeutics stock.
InVivo |
InVivo Therapeutics Holdings Company Number Of Shares Shorted Analysis
InVivo Therapeutics' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current InVivo Therapeutics Number Of Shares Shorted | 17.63 K |
Most of InVivo Therapeutics' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InVivo Therapeutics Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, InVivo Therapeutics Holdings has 17.63 K of outstending shares currently sold short by investors. This is 99.45% lower than that of the Health Care Equipment & Supplies sector and 99.65% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 99.63% higher than that of the company.
InVivo Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InVivo Therapeutics' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InVivo Therapeutics could also be used in its relative valuation, which is a method of valuing InVivo Therapeutics by comparing valuation metrics of similar companies.InVivo Therapeutics is currently under evaluation in number of shares shorted category among its peers.
InVivo Fundamentals
Return On Equity | -0.98 | |||
Return On Asset | -0.54 | |||
Current Valuation | (7.59 M) | |||
Shares Outstanding | 3.11 M | |||
Shares Owned By Insiders | 0.02 % | |||
Shares Owned By Institutions | 3.44 % | |||
Number Of Shares Shorted | 17.63 K | |||
Price To Earning | (1.90) X | |||
Price To Book | 0.1 X | |||
EBITDA | (9.8 M) | |||
Net Income | (9.33 M) | |||
Cash And Equivalents | 13.03 M | |||
Cash Per Share | 9.36 X | |||
Total Debt | 949 K | |||
Debt To Equity | 0.09 % | |||
Current Ratio | 5.64 X | |||
Book Value Per Share | 2.87 X | |||
Cash Flow From Operations | (10.13 M) | |||
Short Ratio | 0.91 X | |||
Earnings Per Share | (3.28) X | |||
Target Price | 37.5 | |||
Beta | 0.66 | |||
Market Capitalization | 995.92 K | |||
Total Asset | 18.82 M | |||
Retained Earnings | (248.62 M) | |||
Working Capital | 15.13 M | |||
Current Asset | 20.74 M | |||
Current Liabilities | 3.31 M | |||
Z Score | -18.62 | |||
Net Asset | 18.82 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |